Your browser doesn't support javascript.
loading
Encorafenib plus cetuximab treatment in BRAF V600E-mutated metastatic colorectal cancer patients pre-treated with an anti-EGFR: An AGEO-GONO case series.
Hafliger, Emilie; Boccaccino, Alessandra; Lapeyre-Prost, Alexandra; Perret, Audrey; Gallois, Claire; Antista, Maria; Pilla, Lorenzo; Lecomte, Thierry; Scartozzi, Mario; Soularue, Emilie; Salvatore, Lisa; Bourgeois, Vincent; Salati, Massimiliano; Tougeron, David; Evesque, Ludovic; Vaillant, Jean-Nicolas; El-Khoury, Reem; Lonardi, Sara; Cremolini, Chiara; Taieb, Julien.
Afiliação
  • Hafliger E; Department of Gastroenterology and Digestive Oncology, SIRIC CARPEM, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP-Paris Centre), Université de Paris, Paris France.
  • Boccaccino A; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy.
  • Lapeyre-Prost A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • Perret A; Department of Medical Oncology, Institut Gustave Roussy, Paris, France.
  • Gallois C; Department of Gastroenterology and Digestive Oncology, SIRIC CARPEM, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP-Paris Centre), Université de Paris, Paris France.
  • Antista M; Department of Oncology and Hemato-oncology, Universita' Degli Studi di Milano, Milan, Italy; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Pilla L; Department of Gastroenterology and Digestive Oncology, SIRIC CARPEM, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP-Paris Centre), Université de Paris, Paris France.
  • Lecomte T; Department of Gastroenterology and Digestive Oncology, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Scartozzi M; Medical Oncology, University of Cagliari, University Hospital, Cagliari, Italy.
  • Soularue E; Department of Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Salvatore L; Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy.
  • Bourgeois V; Department of Digestive Oncology, Centre Hospitalier de Boulogne sur Mer, France.
  • Salati M; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, Modena, Italy.
  • Tougeron D; Department of Gastroenterology and Digestive Oncology, Centre Hospitalier Universitaire de Poitiers, Université de Poitiers, Poitiers, France.
  • Evesque L; Department of Digestive Oncology, Centre Antoine Lacassagne, Nice, France.
  • Vaillant JN; Department of Medical Oncology, Centre de Cancérologie de La Porte de Saint-Cloud, Paris, France.
  • El-Khoury R; Department of Gastroenterology and Digestive Oncology, SIRIC CARPEM, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP-Paris Centre), Université de Paris, Paris France.
  • Lonardi S; Department of Oncology, Veneto Institute of Oncology IOV and IRCCS, Padua, Italy.
  • Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy.
  • Taieb J; Department of Gastroenterology and Digestive Oncology, SIRIC CARPEM, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP-Paris Centre), Université de Paris, Paris France. Electronic address: jtaieb75@gmail.com.
Eur J Cancer ; 168: 34-40, 2022 06.
Article em En | MEDLINE | ID: mdl-35436675

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Carbamatos / Neoplasias Colorretais / Cetuximab Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Carbamatos / Neoplasias Colorretais / Cetuximab Idioma: En Ano de publicação: 2022 Tipo de documento: Article